Taken together, Efp is suggested to promote endometrial cancer by enhancing the signals of NF-κB and its related factors IL6ST and IL18 in addition to downregulation of 14-3-3σ protein, an Efp ubiquitin ligase-substrate (Fig 8F). Here, NFKB1 is linked to endometrial cancer.